Breast Cancer
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were Previously Treated with T-DXd (ACE-Breast-03)
- Details
ClinicalTrials.gov ID:
NCT04829604
Diagnosis Type:
NA
USOR Number:
- Address
,
P: